In clear-cell renal cell carcinoma, for instance, HIFs act upon the p53 pathway to mediate the DNA damage response [44], and overexpression of HIF2A suppresses Hdm2-mediated p53 activity, conferring chemotherapeutic resistance [43]. This evidence concerns the gene TP53 and clear cell renal carcinoma.